Bioactivity:

UR-2922 is an oral antagonist of platelet GPIIb/IIIa. UR-2922 possessed a high affinity for the human platelet receptor (K(d) <1 nM) and a slow dissociation rate (k(off)= 90 min) in vitro. UR-2922 induced no ligand-induced binding sites (LIBS) expression

CAS nr:

220386-56-1

Purity:

98%

Molecular Weight:

519,52

SMILES:

O=C(O)CN1N=C2C(CN(C([C@@H](NC(C3=CC=C(C(N)=N)C=C3)=O)CC4=CC=C([N+]([O-])=O)C=C4)=O)CC2)=C1

Formula:

C25H25N7O6

Pathway:

Target: